Treace Medical Concepts, Inc. (TMCI) Misses Q2 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $30 million versus the consensus estimate of $28.63 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Movano (MOVE) Misses Q2 EPS by 195c